Methocarbamol Safety and Efficacy Guidelines

Critical Safety Considerations

The Mayo Clinic recommends holding methocarbamol on the day of surgical procedures due to its central nervous system depressant effects and potential interactions with anesthetic agents, which can cause drowsiness, dizziness, bradycardia, and hypotension 1
The Mayo Clinic advises against combining methocarbamol with other CNS depressants, including benzodiazepines, opioids, or other sedatives, as this significantly increases respiratory depression risk 1

The Mayo Clinic suggests that in patients with hepatic or renal impairment, methocarbamol elimination is significantly impaired and requires dose reduction 1
The Mayo Clinic recommends that for elderly patients, methocarbamol should be started at lower doses and monitored closely for excessive sedation, confusion, and cardiovascular effects including bradycardia and hypotension 1